| | |
| | |
| Clinical data | |
|---|---|
| Other names | Clonitazene |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H23ClN4O2 |
| Molar mass | 386.88 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Clonitazene is an opioid analgesic of approximately three times the potency of morphine. [2] It is in the nitazene family of benzimidazoles related to etonitazene, an opioid of significantly higher potency. Clonitazene is not currently marketed. It is a controlled substance; in the United States it is a Schedule I Narcotic controlled substance with a DEA ACSCN of 9612 and an established manufacturing quota of 25 grams for 2022.